Literature DB >> 9310232

Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay.

P L Olive1, M R Horsman, C Grau, J Overgaard.   

Abstract

The comet assay was used to estimate radiobiological hypoxic fraction across a full range of tumour oxygenations in C3H mammary tumours implanted into the feet of female CDF1 mice. Tumours were either clamped before irradiation or mice were allowed to breath air, 100% oxygen, carbogen or carbon monoxide for 5-35 min before and during exposure to 15 Gy. For the alkaline comet assay, tumours were excised after irradiation and individual tumour cells were analysed for DNA single-strand breaks. Hypoxic cells were defined as those cells with approximately three times fewer single-strand breaks than aerobic cells. Radiobiological hypoxic fraction was calculated by fitting DNA damage histograms to two normal distributions, representing the response of the aerobic and hypoxic populations. The percentage of hypoxic cells estimated using the comet assay was then compared with hypoxic fraction measured using a clamped tumour control assay. Carbogen and oxygen breathing reduced the normal hypoxic fraction from 14% to 2-3% in this tumour, whereas 75-660 p.p.m. carbon monoxide progressively increased the hypoxic fraction from 18% to 82%. The slope of the line comparing the two methods was 1.23 with 95% confidence limits of 1.12-1.33 (r2 = 0.994). In the SCCVII squamous cell carcinoma growing subcutaneously in C3H mice, a similar correlation was observed between hypoxic fraction measured using the comet assay and hypoxic fraction measured in the same tumour cells using the paired survival curve assay (slope = 1.20 with 95% confidence limits of 1.03-1.37). These results confirm the ability of the comet assay to provide an accurate estimate of radiobiological hypoxic fraction over a wide range of tumour oxygenations and between two tumour types.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310232      PMCID: PMC2228026          DOI: 10.1038/bjc.1997.448

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.

Authors:  R A Gatenby; H B Kessler; J S Rosenblum; L R Coia; P J Moldofsky; W H Hartz; G J Broder
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-05       Impact factor: 7.038

2.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

Authors:  M Nordsmark; M Overgaard; J Overgaard
Journal:  Radiother Oncol       Date:  1996-10       Impact factor: 6.280

Review 3.  Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.

Authors:  H B Stone; J M Brown; T L Phillips; R M Sutherland
Journal:  Radiat Res       Date:  1993-12       Impact factor: 2.841

4.  Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro.

Authors:  A J Franko; C J Koch; B M Garrecht; J Sharplin; D Hughes
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

5.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

6.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data.

Authors:  J E Moulder; S Rockwell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-05       Impact factor: 7.038

7.  Radiation-induced DNA damage in tumors and normal tissues. III. Oxygen dependence of the formation of strand breaks and DNA-protein crosslinks.

Authors:  H Zhang; C J Koch; C A Wallen; K T Wheeler
Journal:  Radiat Res       Date:  1995-05       Impact factor: 2.841

8.  Detection of hypoxic fractions in murine tumors by comet assay: comparison with other techniques.

Authors:  Q Hu; M C Kavanagh; D Newcombe; R P Hill
Journal:  Radiat Res       Date:  1995-12       Impact factor: 2.841

9.  Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation.

Authors:  M R Horsman; A A Khalil; D W Siemann; C Grau; S A Hill; E M Lynch; D J Chaplin; J Overgaard
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-06-15       Impact factor: 7.038

10.  Hypoxic fractions measured in murine tumors and normal tissues using the comet assay.

Authors:  P L Olive; C M Vikse; R E Durand
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-06-15       Impact factor: 7.038

View more
  4 in total

1.  Detection of hypoxia in human brain tumor xenografts using a modified comet assay.

Authors:  Jingli Wang; Jack Klem; Jan B Wyrick; Tomoko Ozawa; Erin Cunningham; Jay Golinveaux; Max J Allen; Kathleen R Lamborn; Dennis F Deen
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

2.  Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.

Authors:  Tove Grönroos; Lise Bentzen; Päivi Marjamäki; Rumi Murata; Michael R Horsman; Susanne Keiding; Olli Eskola; Merja Haaparanta; Heikki Minn; Olof Solin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

3.  Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours.

Authors:  M B Parliament; M J Allalunis-Turner; A J Franko; P L Olive; R Mandyam; C Santos; B Wolokoff
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

4.  Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.

Authors:  P L Olive; R E Durand; J A Raleigh; C Luo; C Aquino-Parsons
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.